y 27632 has been researched along with Bladder Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, S; Ahn, PH; Blancato, J; Choudhury, S; Cullen, K; Dakic, A; Dan, H; Davidson, B; Deeken, JF; Furth, PA; Hubbard, F; Krawczyk, E; Liu, X; Palechor-Ceron, N; Pan, CX; Schlegel, R; Simic, V; Strome, S; Wang, W; Yuan, H; Zheng, YL; Zhou, X | 1 |
| Hutchinson, RC; Krabbe, LM; Margulis, V; Sanli, O; Woldu, SL | 1 |
| Chang, HR; Hsu, YH; Huang, HP | 1 |
| Jiang, L; Luo, W; Wen, J | 1 |
| Chang, HR; Chen, SL; Huang, HP; Hung, TW; Kao, YL; Lian, JD; Wang, CJ; Wu, SW | 1 |
2 review(s) available for y 27632 and Bladder Cancer
| Article | Year |
|---|---|
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.
Topics: Amides; Animals; Biological Specimen Banks; Biopsy; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Differentiation; Cell Line; Cell Line, Tumor; Cellular Reprogramming; Cellular Reprogramming Techniques; Coculture Techniques; Epithelial Cells; Humans; Lung Neoplasms; Male; Models, Biological; Precision Medicine; Prostatic Neoplasms; Proteomics; Pyridines; Urinary Bladder Neoplasms | 2019 |
The Rho GTPase signalling pathway in urothelial carcinoma.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Camellia sinensis; Carcinoma, Transitional Cell; Enzyme Inhibitors; Humans; Neoplasm Metastasis; Plant Extracts; Protein Kinase Inhibitors; Pyridines; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Urinary Bladder Neoplasms | 2018 |
3 other study(ies) available for y 27632 and Bladder Cancer
| Article | Year |
|---|---|
The uremic toxin p-cresol promotes the invasion and migration on carcinoma cells via Ras and mTOR signaling.
Topics: Amides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cresols; Everolimus; Humans; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyridines; ras Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Uremia; Urinary Bladder Neoplasms; Wound Healing | 2019 |
Rho‑associated kinase inhibitor, Y‑27632, inhibits the invasion and proliferation of T24 and 5367 bladder cancer cells.
Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Myosin-Light-Chain Kinase; Neoplasm Invasiveness; Phosphorylation; Protein Processing, Post-Translational; Pyridines; rho-Associated Kinases; Signal Transduction; Urinary Bladder Neoplasms | 2015 |
The suppressive effect of Rho kinase inhibitor, Y-27632, on oncogenic Ras/RhoA induced invasion/migration of human bladder cancer TSGH cells.
Topics: Aged; Aged, 80 and over; Amides; Cell Line, Tumor; Cell Movement; Cytoskeleton; Female; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; ras Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Transfection; Urinary Bladder Neoplasms | 2010 |